D 5 dopamine receptors are required for dopaminergic activation of phospholipase C

Molecular Pharmacology

Volumn 75, Issue 3, 2009, Pages 447-453

  Sahu, Asha ^c   Tyeryar, Kimberly R ^c   Vongtau, Habiba O ^c   Sibley, David R ^b   Undieh, Ashiwel S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; DOPAMINE; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL PHOSPHATE; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; ENZYME ACTIVATION; FRONTAL CORTEX; HIPPOCAMPUS; HYDROLYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; DOPAMINE AGONISTS; ENZYME ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, DOPAMINE D5; SIGNAL TRANSDUCTION; TYPE C PHOSPHOLIPASES;

EID: 62149099240     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.053017     Document Type: Article

References (40)

1. Baufreton J, Garret M, Rivera A, de la Calle A, Gonon F, Duty B, Bioulac B, and Taupignon A (2003) D5 (not Dl) Dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. JNeurosci 23:816-825.
2. Centonze D, Grande C, Usiello A, Gubellini P, Erbs E, Martin AB, Pisani A, Tognazzi N, Bernardi G, Moratalla R, et al. (2003) Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal internenrons. J Neurosci 23:6245-6254.
3. 5 receptor immunolocalization in rat and monkey brain. Synapse 37:125-145.
4. Civelli O, Bunzow JR, and Grandy DK (1993) Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 33:281-307.
5. Cook SJ, Palmer S, Plevin R, and Wakelam MJO (1990) Mass measurement of inositol 1,4,5-trisphosphate and Sn-1,2-diacylglycerol in bombesin-stimulated Swiss 3T3 mouse fibroblasts. Biochem J 265:617-620.
6. Dwivedi Y, Rizavi HS, Rao JS, and Pandey GN (2000) Modifications in the phosphoinositide signaling pathway by adrenal glucocorticoids in rat brain: focus on phosphoinositide-specific phospholipase C and inositol 1,4,5-trisphosphate. J Pharmacol Exp Ther 295:244-254.
7. Felder CC, Jose PA, and Axelrod J (1989) The dopamine-1 agonist SKF82526 stimulates phospholipase-C activity independent of adenylate cyclase. J Pharmacol Exp Ther 248:171-175.
8. Friedman E, Jin LQ, Cai GP, Hollon TR, Drago J, Sibley DR. and Wang HY (1997) D1-like dopaminergic activation of phosphoinositide hydrolysis is independent of D1A dopamine receptors: evidence from D1A knockout mice. Mol Pharmacol 51:6-11.
9. Gnanalingham KK, Hunter AJ, Jenner P, and Marsden CD (1995) Stimulation of adenylate cyclase activity by benzazepine D-l dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat-relationship to circling behaviour. Biochem Pharmacol 49:1185-1193.
10. Hermans E (2003) Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors. Pharmacol Ther 99:25-44.
11. Hersi Al, Kitaichi K, Srivastava LK, Gaudreau P, and Quirion R (2000) Dopamine D-5 receptor modulates hippocampal acetylcholine release. Brain Res Mol Brain Res 76:336-340.
12. Hollon TR, Bek MJ, Lachowicz JE, Ariano MA, Mezey E, Ramachandran R, Wersinger SR, Soares-da-Silva P, Liu ZF, Grinberg A, et al. (2002) Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. JNeu-rosci 22:10801-10810.
13. Hunyady B, Palkovits M, Mózsik G, Molná J, Fehér K, Tóth Z, Zólyomi A, Szalayova I, Key S, Sibley DR, et al. (2001) Susceptibility of dopamine D5 receptor targeted mice to cysteamine. J Physiol Paris 95:147-151.
14. Jin LQ, Goswami S, Cai G, Zhen X, and Friedman E (2003) SKF83959 selectively regulates phosphatidylinositol-liuked D1 dopamine receptors in rat brain. J Neu-rochem 85:378-386.
15. Karpa KD, Lidow MS, Pickering MT, Levenson R, and Bergson C (1999) N-linked glycosylation is required for plasma membrane localization of D5, but not Dl, dopamine receptors in transfected mammalian cells. Mol Pharmacol 56:1071-1078.
16. Lachowicz JE and Sibley DR (1997) Molecular characteristics of mammalian dopamine receptors. Pharmacol Toxicol 81:105-113.
17. Le Crom S, Prou D, and Vernier P (2002) Autocrine activation of adenosine A1 receptors blocks D1A but not D1B dopamine receptor desensitization. J Neuro-chem 82:1549-1552.
18. Lezcano N and Bergson C (2002) D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons. J Neurophysiol 87:2167-2175.
19. 2+ mobilization in Xenopus oocytes. Proc Natl Acad Sci USA 87:2196-2200.
20. Meador-Woodruff JH, Mansour A, Grandy DK, Damask SP, Civelli (X and Watson SJ Jr (1992) Distribution of D5 dopamine receptor MRNA in rat brain. Neurosci Lett 145:209-212.
21. Monsma FJ Jr, Mahan LC, McVittie LD, Gerfen CR, and Sibley DR (1990) Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci USA 87:6723-6727.
22. Montague DM, Striplin CD, Overcash JS, Drago J, Lawler CP, and Mailman RB (2001) Quantification of D1B(D5) receptors in dopamine D1A receptor-deficient mice. Synapse 39:319-322.
23. Neve KA, Seamans JK, and Trantham-Davidson H (2004) Dopamine receptor signaling. J Recept Signal Transduct Res 24:165-205.
24. O'Sullivan GJ, Kinsella A, Sibley DR, Tighe O, Croke DT, and Waddington JL (2005) Ethological resolution of behavioural topography and Dl-like versus D2-hke agonist responses in congenic D5 dopamine receptor mutants: identification of D5: D2-like interactions. Synapse 55:201-211.
25. 35S]GTPgS binding in rat and monkey brain. Neuropharmacology 40:826-837.
26. Panehalingam S and Undie AS (2005) Physicochemical modulation of agonist- induced [35S]GTPgammaS binding: implications for coexistence of multiple funtional conformations of dopamine Dl-like receptors. J Recept Signal Transduct Res 25:125-146.
27. Paspalas CD and Goldman-Rakic PS (2004) Microdomains for dopamine volume neurotransmission in primate prefrontal cortex. J Neurosci 24:5292-5300.
28. Rivera A, Alberti I, Martín AB, Narváez JA, de la Calle A, and Moratalla R (2002) Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype. Eur J Neurosci 16:2049-2058.
29. Rosengarten H and Friedhoff AJ (1998) A phosphoinositide-linked dopamine D1 receptor mediates repetitive jaw movements in rats. Biol Psychiatry 44:1178-1184.
30. Sailer CF and Salama AI (1986) D-1 dopamine receptor stimulation elevates plasma prolactin levels. Eur J Pharmacol 122:139-142.
31. Sidhu A and Niznik HB (2000) Coupling of dopamine receptor subtypes to multiple and diverse G proteins. Int J Dev Neurosci 18:669-677.
32. Tiberi M, Jarvie KR, Silvia C, Falardeau P, Gingrich JA. Godinot N, Bertrand L. Yang-Feng TL, Fremeau RT Jr. and Caron MG (1991) Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor. Proc Natl Acad Sci US A 88:7491-7495.
33. Tomiyama K, Makihara Y, Yamamoto H, O'Sullivan G, Nally RE, Tighe O, Kinsella A. Fienberg AA, Grandy DK, Sibley DR, et al. (2006) Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction 'knockout'. Eur Neuropsychopiharmacol 16:437-445.
34. Undie AS (1999) Relationship between dopamine agonist stimulation of inositol phosphate formation and cytidine diphosphate-diacylglycerol accumulation hi brain slices. Brain Res 816:286-294.
35. Undie AS, Berki AC, and Beardsley K (2000) Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways. Neuropharmacology 39:75-87.
36. Undie AS and Friedman E (1990) Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther 253:987-992.
37. Undie AS and Friedman E (1992) Selective dopaminergic mechanism of dopamine and SKF38393 stimulation of inositol phosphate formation in rat brain. Eur J Pharmacol 226:297-302.
38. Undie AS, Weinstock J, Sarau HM, and Friedman E (1994) Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J Neurochem 62:2045-2048.
39. Yasumoto F, Negishi T, Ishii Y, Kyuwa S, Kuroda Y, and Yoshikawa Y (2004) Endogenous dopamine maintains synchronous oscillation of intracellular calcium in primary cultured-mouse midbrain neurons. Cell Mol Neurobiol 24:51-61.
40. Zhen X, Uryu K, Wang HY, and Friedman E (1998) D1 dopamine receptor agonists mediate activation of P38 mitogen-activated protein kinase and C-Jun amino-terminal kinase by a protein kinase A-dependent mechanism in SK-N-MC human neuroblastoma cells. Mol Pharmacol 54:453-458.